Wells Fargo’s Palvella Therapeutics, Inc. Common Stock PVLA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$82.6K Buy
3,665
+3,615
+7,230% +$81.5K ﹤0.01% 4894
2025
Q1
$1.4K Hold
50
﹤0.01% 5729
2024
Q4
$600 Sell
50
-10
-17% -$120 ﹤0.01% 5797
2024
Q3
$995 Hold
60
﹤0.01% 5715
2024
Q2
$589 Sell
60
-10
-14% -$98 ﹤0.01% 5750
2024
Q1
$1.02K Buy
70
+10
+17% +$146 ﹤0.01% 5754
2023
Q4
$867 Sell
60
-12
-17% -$173 ﹤0.01% 5819
2023
Q3
$1.71K Buy
72
+3
+4% +$71 ﹤0.01% 5739
2023
Q2
$920 Hold
69
﹤0.01% 6027
2023
Q1
$5.35K Buy
69
+1
+1% +$78 ﹤0.01% 5714
2022
Q4
$5.7K Hold
68
﹤0.01% 5406
2022
Q3
$7K Hold
68
﹤0.01% 5497
2022
Q2
$10K Sell
68
-6
-8% -$882 ﹤0.01% 5472
2022
Q1
$18K Buy
74
+7
+10% +$1.7K ﹤0.01% 5714
2021
Q4
$20K Sell
67
-9
-12% -$2.69K ﹤0.01% 5826
2021
Q3
$32K Hold
76
﹤0.01% 5483
2021
Q2
$23K Sell
76
-5,601
-99% -$1.7M ﹤0.01% 5519
2021
Q1
$1.17M Buy
5,677
+3,359
+145% +$690K ﹤0.01% 3891
2020
Q4
$464K Sell
2,318
-128
-5% -$25.6K ﹤0.01% 4486
2020
Q3
$405K Buy
2,446
+606
+33% +$100K ﹤0.01% 4382
2020
Q2
$457K Buy
1,840
+244
+15% +$60.6K ﹤0.01% 4276
2020
Q1
$291K Buy
1,596
+441
+38% +$80.4K ﹤0.01% 4291
2019
Q4
$334K Buy
1,155
+1
+0.1% +$289 ﹤0.01% 4547
2019
Q3
$315K Buy
1,154
+42
+4% +$11.5K ﹤0.01% 4547
2019
Q2
$419K Sell
1,112
-69
-6% -$26K ﹤0.01% 4380
2019
Q1
$317K Sell
1,181
-9
-0.8% -$2.42K ﹤0.01% 4526
2018
Q4
$254K Buy
1,190
+80
+7% +$17.1K ﹤0.01% 4608
2018
Q3
$497K Sell
1,110
-83
-7% -$37.2K ﹤0.01% 4338
2018
Q2
$484K Buy
1,193
+243
+26% +$98.6K ﹤0.01% 4372
2018
Q1
$518K Sell
950
-83
-8% -$45.3K ﹤0.01% 4257
2017
Q4
$623K Buy
1,033
+806
+355% +$486K ﹤0.01% 4146
2017
Q3
$105K Buy
+227
New +$105K ﹤0.01% 4993